Список литературы
Шеклакова М.Н. Оценка эффективности применения нового препарата пиритиона цинка Цинокап® в терапии больных себорейным дерматитом // Вестник дерматологии и венерологии. 2010. Т. 86. № 3. С. 49–55. eLIBRARY ID: 15131483.
Abbas Z., Ghodsi S.Z., Abedeni R. Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial // Dermatol. Pract. Concept. 2016. Vol. 6. N. 3. P. 11–16. DOI: https://doi.org/10.5826/dpc.0603a04. PMID: 27648378; PMCID: PMC5006547.
Apasrawirote W., Udompataikul M., Rattanamongkolgul S. Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis // J. Med. Assoc. Thai. 2011. Vol. 94. N. 6. P. 756–760. PMID: 21696088.
Barba A., Piubello W., Vantini I. et al. Skin lesions in chronic alcoholic pancreatitis // Dermatologica. 1982. Vol. 164. N. 5. P. 322–326. DOI: https://doi.org/10.1159/000250109. PMID: 6212271.
Bukvić Mokos Z., Kralj M., Basta-Juzbašić A., Lakoš Jukić I. Seborrheic dermatitis: an update // Acta Dermatovenerol. Croat. 2012. Vol. 20. N. 2. P. 98–104. PMID: 22726283.
Chattopadhyay S.P., Arora P.N., Anand S., Sharma S.D. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses // Indian J. Dermatol. 1987. Vol. 32. N. 2. P. 41–44. PMID: 3453353.
Chatzikokkinou P., Sotiropoulos K., Katoulis A. et al. Seborrheic dermatitis — an early and common skin manifestation in HIV patients // Acta Dermatovenerol. Croat. 2008. Vol. 16. N. 4. P. 226–230. PMID: 19111149.
Choeng W.K., Yeung C.K., Torsekar R.G. et al. Treatment of seborrhoeic dermatitis in Asia: a consensus guide // Skin Appendage Disord. 2015. Vol. 1. N. 4. P. 187–196. DOI: https://doi.org/10.1159/000444682. Epub 2016 Mar 23. PMID: 27386464; PMCID: PMC4908450.
Cicek D., Kandi B., Bakar S., Turgut D. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study // J. Dermatolog. Treat. 2009. Vol. 20. N. 6. P. 344–349. DOI: https://doi.org/10.3109/09546630802687349. PMID: 19954391.
Clark G.W., Pope S.M., Jaboori K.A. Diagnosis and treatment of seborrheic dermatitis // Am. Fam. Physician. 2015. Vol. 91. N. 3. P. 185–190. PMID: 25822272.
Cömert A., Bekiroglu N., Gürbüz O., Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study // Am. J. Clin. Dermatol. 2007. Vol. 8. N. 4. P. 235–238. DOI: https://doi.org/10.2165/00128071-200708040-00005. PMID: 17645378.
Cribier B., Samain F., Vetter D. et al. Systematic cutaneous examination in hepatitis C virus infected patients // Acta Derm. Venereol. 1998. Vol. 78. N. 5. P. 355–357. DOI: https://doi.org/10.1080/000155598443051. PMID: 9779254.
Danby F.W., Maddin W.S., Margesson L.J., Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff // J. Am. Acad. Dermatol. 1993. Vol. 29. N. 6. P. 1008–1012. DOI: https://doi.org/10.1016/0190-9622(93)70282-x. PMID: 8245236.
Davies D.B., Boorman G.C., Shuttleworth D. Comparative efficacy of shampoos containing coal tar (4.0% w/w; Tarmed™), coal tar (4.0% w/w) plus ciclopirox olamine (1.0% w/w; Tarmed™ AF) and ketoconazole (2.0% w/w; Nizoral™) for the treatment of dandruff/seborrhoeic dermatitis // J. Dermatolog. Treat. 1999. Vol. 10. N. 3. P. 177–183. DOI: https://doi.org/10.3109/09546639909056025. Epub 2009 Jul 12.
Elish D., Silverberg N.B. Infantile seborrheic dermatitis // Cutis. 2006. Vol. 77. N. 5. P. 297–300. PMID: 16776285.
Ficicioglu S., Piskin S. Dermoscopic findings in psoriasis and seborrheic dermatitis on the scalp and correlation with disease severity // Med. Sci. 2018. Vol. 7. N. 1. P. 118–121. DOI: https://doi.org/10.5455/medscience.2017.06.8731.
Ghodsi S.Z., Abbas Z., Abedeni R. Efficacy of oral itraconazole in the treatment and relapse prevention of moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial // Am. J. Clin. Dermatol. 2015. Vol. 16. N. 5. P. 431–437. DOI: https://doi.org/10.1007/s40257-015-0133-9. Epub 2015 May 28. PMID: 26016699.
Gilbertson K., Jarrett R., Bayliss S.J., Berk D.R. Scalp discoloration from selenium sulfide shampoo: a case series and review of the literature // Pediatr. Dermatol. 2012. Vol. 29. N. 1. P. 84–88. DOI: https://doi.org/10.1111/j.1525-1470.2011.01410.x. Epub 2011 Mar 31. PMID: 21453309.
Goldust M., Rezaee E., Rouhani S. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis // Ann. Parasitol. 2013. Vol. 59. N. 1. P. 25–29. PMID: 23829055.
Gupta A.K., Bluhm R. Seborrheic dermatitis // J. Eur. Acad. Dermatol. Venereol. 2004. Vol. 18. N. 1. P. 13–26. DOI: https://doi.org/10.1111/j.1468-3083.2004.00693.x. MID: 14678527.
Gupta A.K., Richardson M., Paquet M. Systematic review of oral treatments for seborrheic dermatitis // J. Eur. Acad. Dermatol. Venereol. 2014. Vol. 28. N. 1. P. 16–26. DOI: https://doi.org/10.1111/jdv.12197. Epub 2013 Jun 26. PMID: 23802806.